Find It Early Act
Introduced April 10, 2025 · Last action April 10, 2025
Plain English Summary
This bill requires health insurance plans—including Medicare, Medicaid, private insurance, TRICARE, and Veterans Affairs—to cover additional breast cancer screenings and diagnostic imaging with no cost-sharing for individuals at increased risk of breast cancer or with dense breast tissue, effective January 1, 2026. Coverage includes 2D/3D mammograms, ultrasound, MRI, and molecular breast imaging with no frequency limits, determined by American College of Radiology or National Comprehensive Cancer Network guidelines.
Who benefits
Women at increased risk of breast cancer or with heterogeneously or extremely dense breast tissue who are insured through private plans, Medicare, Medicaid, TRICARE, or Veterans Affairs; women whose providers determine they need additional screening based on age, race, ethnicity, or family history; imaging centers and breast cancer diagnostic providers who will perform additional screenings; American College of Radiology and National Comprehensive Cancer Network whose clinical guidelines become the standard for eligibility determination.
Who pays / loses
Private health insurers and group health plans bear increased claims costs from expanded preventive screening coverage; Medicare program bears costs for additional beneficiary screenings; state Medicaid programs bear costs for eligible individuals' expanded imaging coverage; TRICARE and Department of Defense bear costs for military beneficiaries and retirees; Veterans Affairs bears costs for veterans' expanded screening programs.
Funding & Lobbying Interests
Breast imaging equipment manufacturers (GE Healthcare, Siemens Healthineers, Hologic, Canon, Fujifilm) and molecular breast imaging vendors (Dilon Technologies, CMR Naviscan) benefit from increased volume of prescribed imaging studies. Diagnostic imaging centers and breast imaging radiologists gain increased procedure volume and billings. Organizations such as the American College of Radiology and National Comprehensive Cancer Network gain institutional credibility and de facto standard-setting authority. Sponsors Klobuchar (D-MN) and Marshall (R-KS) appear to represent a broad coalition: Klobuchar's Minnesota base includes major medical device manufacturers; Marshall represents a rural Kansas district where geographic access to advanced imaging is limited. Nonprofit advocacy groups such as Susan G. Komen and the National Breast Cancer Coalition typically support such legislation, though specific sponsor finance data was not provided.
Political Impact
Affected Groups
Women with personal or family history of breast cancer; women aged 40–49 (often excluded from routine screening); women of African American descent (higher breast cancer mortality rates); women with dense breast tissue (estimated 40% of women aged 40–74); uninsured and underinsured women who may gain coverage via Medicaid expansion provisions; military service members and retirees; veterans; low-income women in states with Medicaid programs.
Political Subtext
Proponents argue this bill closes a coverage gap by ensuring early detection for high-risk individuals and those with dense breast tissue, which are associated with higher breast cancer risk and false negatives on standard mammography. Supporters cite state dense-breast notification laws (in 38 states) and emerging evidence that supplemental imaging improves cancer detection in dense breast tissue populations. Critics may argue that the bill mandates coverage without specific cost estimates or evidence thresholds for clinical benefit; that it lacks frequency limits in the bill language (instead delegating limits to professional guidelines, which may change); and that it expands preventive coverage without Congressional Budget Office cost analysis. Non-partisan evidence: supplemental imaging (ultrasound, MRI) does improve cancer detection in women with dense breast tissue and high risk, but increases false-positive rates and anxiety; the American Cancer Society, U.S. Preventive Services Task Force, and professional radiology societies have varying recommendations on supplemental screening intensity and frequency. The bill defers to ACR and NCCN criteria rather than establishing statutory frequency caps, which may create ambiguity about what constitutes 'medically necessary' screening.
Real-World Stakes
If this passes, tens of millions of women will gain access to advanced breast imaging (ultrasound, MRI, molecular imaging) without out-of-pocket costs, potentially increasing early-stage breast cancer detection and reducing advanced-stage diagnoses. Health insurance claims for breast imaging will rise substantially across all payers; private insurers may adjust premiums; Medicare and Medicaid program costs increase; TRICARE and VA budgets face higher utilization. Based on state dense-breast notification law implementation (starting 2009), states that mandated notification and coverage saw increased supplemental imaging use but also increased benign biopsy rates; no comprehensive national cost analysis exists for unlimited supplemental screening. The bill's reliance on professional society guidelines (ACR, NCCN) rather than statutory frequency limits means coverage scope may shift if societies revise recommendations. Precedent: the ACA's coverage of preventive services without cost-sharing (e.g., USPSTF Grade A and B recommendations) similarly shifted costs to insurers while reducing patient barriers; the Breast Cancer and Environmental Research Act (2015) and various state dense-breast laws created patchwork coverage that this bill aims to standardize. No direct precedent exists for unlimited-frequency preventive imaging coverage across all U.S. insurance types.
Sponsor
Sponsor information not available.
Vote Record
No recorded votes.
Campaign Finance — Primary Sponsor
No campaign finance data available yet.
501(c)(4) disclosure: Contributions from 501(c)(4) "dark money" organizations are not required to be publicly disclosed and are not reflected in the figures above. Data sourced from FEC public disclosure filings.
Community Discussion
Share this bill
Sign in to join the discussion.
No comments yet. Be the first.